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Abstract
Chagas disease is an endemic zoonosis native to the Americas and is caused by the kinetoplastid protozoan parasite
Trypanosoma cruzi. The parasite is also highly genetically diverse, with six discrete typing units (DTUs) reported TcI – TcVI.
These DTUs broadly correlate with several epidemiogical, ecological and pathological features of Chagas disease. In this
manuscript we report the most comprehensive evaluation to date of the genetic diversity of T. cruzi in Venezuela. The
dataset includes 778 samples collected and genotyped over the last twelve years from multiple hosts and vectors, including
nine wild and domestic mammalian host species, and seven species of triatomine bug, as well as from human sources. Most
isolates (732) can be assigned to the TcI clade (94.1%); 24 to the TcIV group (3.1%) and 22 to TcIII (2.8%). Importantly, among
the 95 isolates genotyped from human disease cases, 79% belonged to TcI - a DTU common in the Americas, however, 21%
belonged to TcIV- a little known genotype previously thought to be rare in humans. Furthermore, were able to assign
multiple oral Chagas diseases cases to TcI in the area around the capital, Caracas. We discuss our findings in the context of T.
cruzi DTU distributions elsewhere in the Americas, and evaluate the impact they have on the future of Chagas disease
control in Venezuela.
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Introduction
Trypanosoma cruzi, the etiological agent of Chagas disease,
infects approximately 8 million people in Latin America [1]. A
further 20 million people are at risk of infection. Chagas disease
is widely dispersed across 21 countries in the Americas, with a
natural distribution (in wild transmission cycles) from the
Southern States of the USA [2] to Central Argentina [3].
Chagas disease is a vector-borne zoonosis, and transmission is
generally achieved via the infected faeces of various triatomine
bug species, evacuated during a blood meal. Infection is
maintained in wild transmission cycles by numerous mamma-
lian reservoir hosts, especially opossums (Didelphis sp.) and
armadillos (Dasypus sp.) [4]. Human infection occurs at foci
throughout the natural distribution of T. cruzi where triatomines
have adapted to exploit the domestic setting, but also orally (via
ingestion of triatomine contaminated foodstuffs) in endemic
countries, as well as via blood transfusion, organ transplantation
and congenital infection in and outside of areas of traditional
endemicity [1].
T. cruzi is likely to be ancient and indigenous to the Americas
[5,6]. Indeed, the parasite demonstrates considerable genetic
diversity as initially revealed by multilocus enzyme electrophoresis
(MLEE) [7–9]. These early studies supported the typing of the T.
cruzi into three main groups or zymodemes, called Z1, Z2 and Z3.
The implementation of further molecular techniques in combina-
tion with MLEE, allow the division of the T. cruzi species in six
groups or discrete typing units (DTU), denoted TcI, TcIIa, TcIIb,
TcIIc, TcIId and TcIIe [10]. More recently, in a meeting of
experts held in Brazil [11], a new nomenclature was recom-
mended for the intraspecific classification of T. cruzi discrete typing
units (DTUs) into TcI, TcII, TcIII, TcIV, TcV and TcVI.
However, while the T. cruzi DTUs are relatively genetically stable
in space and time, their evolutionary, ecological and epidemiolgi-
cal significance is far from clear [4,12]. Some limited patterns
emerge (reviewed in [13]), TcII, TcV and TcVI seem largely
restricted to domestic transmission cycles south of the Amazon
basin, where they cause considerable human disease. TcIII is
infrequent from domestic sources, strongly associated with Dasypus
novemcinctus in terrestrial transmission cycles, and found throughout
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South America. TcIV is enigmatic, so far uncommon among
humans, broadly limited to Amazonia and Northern South
America and most commonly reported from primates; TcI is the
most abundant of all T. cruzi lineages in silvatic transmission cycles,
where it primarily infects arboreal marsupials and triatomines in
lowland tropical South America and terrestrial rodents and
triatomines in arid rocky ecotopes. TcI is the major cause of
human disease in northern South America, but also reported from
chagasic patients sporadically throughout the Southern Cone.
In Venezuela, previous studies revealed TcI in humans,
triatomine bugs, wild and domestic mammals [8,14–21]. T. cruzi
genotype TcIV has been reported infecting humans, triatomine
bugs and the primate Saimiri sciureus [8,14]. Infection with TcIII
has been found in D. novemcinctus and associated Panstrongylus sp.
nymphs [22]. Overall, however, reports of T. cruzi DTUs in
Venezuela are focal and fragmented. In the present study we
report T. cruzi genotype data from 778 T. cruzi strains systemat-
ically genotyped using multiple molecular markers in our
laboratory over the past 12 years. These include samples obtained
from 17 of Venezuela’s 24 states, acute and chronic chagasic
patients, seven species of triatomine bugs, nine species of wild and
domestic mammals, and representatives of silvatic, peridomestic
and domestic cycles. These isolates have been classified to DTU
level using biochemical and molecular techniques. Our data
represent a uniquely comprehensive record of the six T. cruzi
DTUs in Venezuela and a valuable addition to our understanding
of the parasite’s genetic diversity in South America.
Materials and Methods
Ethics statement
All procedures including use of laboratory reared mice and wild
mammals, have been conducted following the regulations for the
use of animals in Scientific Research included in the Code of
Ethics for Life, of the National Fund for Scientific, Technological
and Innovation; Ministery for Science and Technology, with the
approval of the Commission on Ethics, Bioethics and Biodiversity,
documents Nu 7513, 07 Dec. 2007 and Nu 4403, 28 Oct. 2010,
based on the communication of approval of protocols by the
Scientific Ethical Committee of the Institute of Tropical Medicine,
Faculty of Medicine, Universidad Central de Venezuela, docu-
ment Nu CEC-IMT 19/2009, 13 Dec. 2005, 20 Jun. 2007, 22
Nov. 2009. In the same way, all studies involving patients and
inhabitants at endemic communities, have been conducted
according to the regulations for the research in humans, stated
in the Code of Ethics for Life, of the National Fund for Scientific,
Technological and Innovation, Ministery for Science and Tech-
nology, with the approval of the Commission on Ethics, Bioethics
and Biodiversity, documents Nu 7513, 07 Dec. 2007 and Nu 4403,
28 Oct. 2010, based on the communication of approval by the
Scientific Ethical Committee of the Institute of Tropical Medicine,
Faculty of Medicine, Universidad Central de Venezuela, docu-
ment Nu CEC-IMT 19/2009, 20 Jun. 2007, 13 Dec. 2005, 22
Nov. 2009. All subjects were asked for their voluntary participa-
tion in this study by providing a written informed consent under
the supervision and approval of the above mentioned Ethical
Committees. After being sure that the informed consent was
clearly understood by each individual, it was signed by every
person, indicating the citizen identification card number (C.I.), in
every particular case. The search for triatomine bugs inside the
houses, peridomestic and surrounding areas was done with the
owners/residents permission. The tests for Chagas disease on
domestic mammals were carried out with the owner’s permission
and the procedure was approved by the Scientific Ethical
Committee of the Institute of Tropical Medicine, Faculty of
Medicine, Universidad Central de Venezuela, document Nu CEC-
IMT 19/2009, 20 Jun. 2007, 13 Dec. 2005, 22 Nov. 2009.
Parasite isolation
T. cruzi isolates were obtained from chagasic outpatients from
different geographical areas of Venezuela attending the Instituto
de Medicina Tropical (IMT) of the Universidad Central de
Venezuela (UCV) as well as chagasic patients living in rural areas
of Venezuela where Chagas disease is endemic. Another group of
patients were from urban areas of Caracas, the Capital city, and
the neighbor State Vargas (see Table 1), all of them in the acute
phase of the disease, presumably infected via oral transmission. All
patient isolates were collected under informed consent following
the ethical permissions of the Research Ethics Commission of the
Institute of Tropical Medicine, Faculty of Medicine, Universidad
Central de Venezuela. The second group of T. cruzi isolates was
obtained from seven different species of triatomine bug and
originated from insects brought to the IMT by members of the
public and those obtained during fieldwork. Triatomines were
identified to species level according to Lent and Wygodzinksy,
1979 [23] and in some case via molecular methods (as part of
Fitzpatrick et al., 2008 [24]) as detailed in Table 1. A third group of
T. cruzi isolates was found infecting nine species of wild and
domestic mammal (see Table 2), captured during multiple field
expeditions to endemic and urban regions.
Parasite culture and DNA isolation
Parasites were isolated via several different techniques. Briefly:
parasites from chagasic patients were obtained by indirect
xenodiagnosis, by hemoculture of peripheral blood, or by i.p.
inoculation of Balb/c mice with peripheral blood. From wild and
domestic mammals, parasites were isolated by direct xenodiagno-
sis, by hemoculture from peripheral or cardiac blood, or by i.p.
inoculation of Balb/c mice with cardiac blood. From triatomine
bugs, naturally infected or used in the xenodiagnosis, the parasites
were isolated by direct culture of feces in blood agar or by i.p.
inoculation of Balb/c mice with bug faeces. To achieve
xenodiagnosis, we used 12 to 15 instar nymphs of Rhodnius prolixus,
3rd or 4th stage, reared in the laboratory. Initially the parasites
were grown in biphasic medium blood-agar followed by culture in
Author Summary
Chagas disease is caused by a protozoan parasite called
Trypanosoma cruzi. T. cruzi infects a wide variety of
mammal species in Latin America as well as man, and is
spread by multiple species of blood sucking triatomine
insect vectors. The presence of genetic diversity in T. cruzi
in the Americas is well established, with six different major
genetic types in circulation. The genetic diversity of T. cruzi
in Venezuela is relatively poorly understood. In this work
we present the results from the genotyping of over seven
hundred isolates from 17 of the 24 states. Our dataset
comprises strains isolated from wild and domestic animals,
several species of triatomine vector, as well as from human
Chagas disease cases, including those associated with oral
transmission of T. cruzi. Amongst other findings, our data
reveal a surprisingly high frequency of atypical genotypes
in humans, particularly TcIV, which has rarely been
reported. We evaluate our findings in the context of T.
cruzi diversity elsewhere in the Americas, and assess the
impact they have on the future of Chagas disease control
in Venezuela.
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supplemented RPMI 1640 medium as described by Miles (1993)
[25].
Parasite phenotypic and genotyping strategies
A phenotypic analysis was initially done using the isoenzyme
technique as described by Miles et al,. (1977) [7]. For this analysis
we used phosphoglucomutase (E.C.2.7.5.1, PGM) and glucose
phosphate isomerase (E.C.S.3.l.9, GPI) enzymes (Figure 1). They
were examined by thin-layer starch gel electrophoresis as
described by Carrasco et. al. (1996) [26]. Random Amplified
Polymorphic DNA (RAPD) genotyping (Figure 2) was performed
as in Carrasco et al., (1996) [26]. PCR reactions for RAPD typing
were achieved using primers A1, A2, L4 and L5 (Table 3). Each
reaction took place in a 20 mL final volume containing 10 mM
Tris HCl (pH 8.8) buffer, 0.2 Mm of each dNTP, 20 pg of primer,
1.0 unit of Taq DNA polymerase (Invitrogen, Brazil) and included
5 ng of whole genomic DNA. Reaction conditions were as follows:
two cycles at 95uC for 5 min, 30uC for 2 min and 72uC for 1 min,
32 cycles at 95uC for 1 min, 40uC for 2 min, and 72uC for 1 min,
and a final extension cycle at 72uC for 5 min. Primer sequences
are listed in Table 3. PCR restriction fragment length polymor-
phism (PCR-RFLP) genotyping (Figure 3) targeted two loci:
Glucose phosphate isomerase (GPI) and Heat Shock Protein 60
(HSP60) genes were amplified and cut using restriction enzymes
HhaI and EcoRV respectively, following protocols set out in
Westenberger et al. 2005 [27].
All PCR products were visualised on 2.5% agarose gels
(Invitrogen, USA) using appropriate molecular weight markers.
Table 1. Geographical distribution of Trypanosoma cruzi genotypes from different hosts in Venezuela.
State Host TcI TcIII TcIV Total State Host TcI TcIII TcIV Total
Anzoa´tegui Human 3 0 4 7 Lara Human 8 0 2 10
Panstrongylus geniculatus 2 0 0 2 Rhodnius prolixus** 5 0 0 5
Rhodnius prolixus* 35 0 0 35 Me´rida Human 1 0 0 1
Triatoma maculata 8 0 0 8 Miranda Human 6 0 1 7
Artibeus jamaicensis 1 0 0 1 E. mucronatus 2 0 0 2
Dicotyles tajacu 1 0 0 1 Panstrongylus geniculatus 170 2 0 172
Didelphis marsupialis 18 0 0 18 Panstrongylus
rufotuberculatus
1 0 0 1
Dasypus novemcinctus 0 4 0 4 Rhodnius pictipes 1 0 0 1
Odocoileus virginianus 1 0 0 1 Triatoma nigromaculata 1 0 0 1
Aragua Human 0 0 1 1 Didelphis marsupialis 4 0 0 4
Panstrongylus geniculatus 4 0 0 4 Rattus rattus 2 0 0 2
Rhodnius pictipes 1 0 0 1 Monagas Human 1 0 0 1
Barinas Human 2 0 1 3 Portuguesa Human 3 0 4 7
Panstrongylus geniculatus 0 1 0 1 Panstrongylus geniculatus 0 1 0 1
Rhodnius prolixus** 37 0 0 37 Rhodnius prolixus** 80 0 3 83
Triatoma maculata 2 0 0 2 Canis familiaris 1 0 0 1
Didelphis marsupialis 10 0 0 10 Didelphis marsupialis 8 0 0 8
Dasypus novemcinctus 0 9 0 9 Mus musculus 1 0 0 1
Rattus norvegicus 1 0 0 1 Sucre Human 5 0 1 6
Carabobo Human 1 0 0 1 Panstrongylus geniculatus 3 4 0 5
Panstrongylus geniculatus 1 0 0 1 Triatoma maculata 2 0 0 2
Rhodnius prolixus* 7 0 0 7 Didelphis marsupialis 4 0 0 4
Didelphis marsupialis 1 0 0 1 Ta´chira Human 9 0 1 10
Cojedes Human 2 0 1 3 Trujillo Human 5 0 1 6
Panstrongylus geniculatus 2 0 0 2 Rhodnius prolixus** 3 0 0 3
Rhodnius prolixus** 5 0 0 5 Rattus rattus 1 0 0 1
DC Human 16 0 0 16 Didelphis marsupialis 2 0 0 2
Panstrongylus geniculatus 163 0 0 163 Vargas Human 3 0 0 3
Didelphis marsupialis 1 0 0 1 Panstrongylus geniculatus 18 1 1 20
Rattus rattus 44 0 0 44 Yaracuy Human 4 0 0 4
Rhodnius prolixus* 1 0 0 1 Total 732 22 24 778
Gua´rico Human 6 0 3 9
Triatoma maculata 1 0 0 1
Didelphis marsupialis 1 0 0 1
**Morphological and molecular identification.
*Morphological identification only.
doi:10.1371/journal.pntd.0001707.t001
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Several DTU reference strains were included for comparison and
are listed in Table 4.
Results
In total we genotyped 778 isolates to DTU level. Images from
selected electrophoretic gels for the various genotyping techniques
are displayed in Figures 1–3. T. cruzi isolates genotyped are
distributed across 17 endemic states in Venezuela. The genotype
analysis of all the isolates shows that 732 belong to TcI group
(94.1%); 24 isolates to TcIV group (3.1%) and 22 to TcIII group
(2.8%). We recovered and genotyped 95 isolates from humans.
Among these, 20 isolates were designated to TcIV (21.0%), with a
further 75 typed as TcI (79.0%). Interestingly, TcIV was widely
distributed across Venezuela as a secondary agent of human
infection. Samples are presented by genotype, state and abun-
dance in Figure 4 and Table 1 and 5. TcIII, although
underrepresented in the total dataset (N = 22), was nonetheless
conspicuous in its absence from humans. Full details of sample
codes and genotypes are included in Tables S1, S2 & S3.
Among nine mammal species identified with T. cruzi infection,
TcI was the DTU most frequently encountered (102; 88.7%;
Table 2 and 5). TcIII was also apparent (13; 11.3%), however,
uniquely among nine banded armadillos (Dasypus novemcinctus). By
state, TcIII was found with greatest frequency in Barinas and
Anzoategui. These states were also the only ones from which D.
novemcinctus was sampled and the presence of TcIII cannot
therefore be discounted elsewhere. TcIV was absent from the
infected silvatic mammals captured as part of this study, and we
are thus far unable to establish the natural reservoir host of this
lineage in Venezuela.
Triatomines yielded the vast majority of isolates examined
(N = 568). Correspondingly, the greatest diversity of distinct T.
cruzi DTUs (TcI, TcIII, TcIV) was also encountered among the
triatomines. As previously, TcIII and TcIV represented a minority
of the total number of genotypes sampled (2.3%). Among seven
species of triatomine, TcIII was only recovered from P. geniculatus.
This triatomine bug also yielded a single TcIV strain in Vargas
state, close to the Distrito Capital (near Caracas), where TcI and
TcIII were also identified in circulation among the same species.
Interestingly, TcIV was also present among domestic R. prolixus in
Portuguesa, where one insect showed single infection with TcIV
and two others presented mixed infection of TcI and TcIV (see
Table S2), in this case reflecting the high proportion of human
TcIV cases in this state.
Discussion
The 778 genotype records from humans, mammals and
triatomine vectors presented in this study dramatically expand
our understanding of the geographical distribution of T. cruzi
genotypes in Venezuela.
Perhaps most significant is the frequent occurrence of TcIV
among human Chagas disease cases in Venezuela. So far reports
of this DTU in humans are sparse. They include at most half a
dozen cases across Northern Brazil [8,28], as well as some
historical cases from Venezuela [8]. However, given the continuity
of the ecotopes and major vector distributions (e.g. R. prolixus in
Table 2. Trypanosoma cruzi genotypes from different host
species in Venezuela.
Host Species TcI TcIII TcIV Total
Bugs Eratyrus mucronatus 2 0 0 2
Panstrongylus geniculatus 363 9 1 373
Panstrongylus
rufotuberculatus
1 0 0 1
Rhodnius pictipes 2 0 0 2
Rhodnius prolixus 173 0 3 176
Triatoma maculata 13 0 0 13
Triatoma nigromaculata 1 0 0 1
Mammals Rattus rattus 47 0 0 47
Rattus norvegicus 1 0 0 1
Canis familiaris 1 0 0 1
Dasypus novemcinctus 0 13 0 13
Mus musculus 1 0 0 1
Tayassu sp 1 0 0 1
Artibeus jamaicensis 1 0 0 1
Odocoileus virginianus 1 0 0 1
Didelphis marsupialis 49 0 0 49
Human 75 0 20 95
Total 732 22 24 778
doi:10.1371/journal.pntd.0001707.t002
Figure 1. Isoenzyme profiles of GPI and PGM from representative circulating Venezuelan Trypanosoma cruzi strains. Loading order, left
to right: TcI, WA250 cl 10B; TcII, Esmeraldo cl2; TcIV, CanIII cl 1; 1, 8839(TcIV); 2, 8196(TcIV); 3, 10141(TcI); 4, 10610(TcIV); 5, 8089(TcI); 6, 6872(TcI); 7,
PGN23(TcI); 8, PGN27(TcIV); 9, PGN31(TcI).
doi:10.1371/journal.pntd.0001707.g001
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Venezuela) in the areas from which these cases originate,
especially the lowland Llanos region which lies between Venezuela
and Colombia, we suspect that the distribution of human TcIV
cases is likely underreported. We characterised TcIV from
domestic R. prolixus at one study site in Portuguesa, and from
domestic P. geniculatus in Vargas State (Table 1, Figure 4). As with
TcI, therefore, this DTU may be actively maintained in domestic
cycles in Venezuela. The risk of epizootic transmission events
cannot be defined until the silvatic abundance and niche of TcIV
can be established. In Brazil, and Bolivia, silvatic TcIV has been
isolated primarily from primates and Rhodnius species triatomines
[14,28]. There are also limited records of this genotype from
Panstrongylus species and the coati Nasua nasua [28–30]. In theory,
TcIV should also be primarily located in arboreal cycles in
Venezuela, associated with primates and Rhodnius species. Indeed,
there is a single TcIV record from the squirrel monkey Samairi
scuireus in Venezuela [14]. Targeted capture efforts should improve
our understanding of enzootic TcIV in Venezuela, as well as help
Figure 2. RAPD profiles of representative circulating Venezuelan Trypanosoma cruzi strains. Loading order, left to right A: 1, CanIII cl 1
(TcIV); 2, Esmeraldo cl2 (TcII); 3, WA250 cl 10B (TcI); 4, 8839(TcIV); 5, 8196(TcIV); 6, 10141(TcI); 7, 10610(TcIV); 8, 8089(TcI); 9, 6872(TcI); 10, PGN23(TcI);
11, PGN27(TcIV); 12, PGN31(TcI); L, 1 kb DNA Ladder. B: 1, CanIII cl1 ; 2, Esmeraldo cl2; 3, WA250 cl 10B; 4, 11932; 5, 7082; 6, 8104; 7, 7570; 8, 7780; 9,
SJ1097; 10, pgn2; 11, PGCHG; 12, CD45.
doi:10.1371/journal.pntd.0001707.g002
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Figure 3. PCR-RFLP genotyping profiles of Venezuelan Trypanosoma cruzi strains. Each pair of lanes shows undigested PCR product
followed by restriction digest products for GPI (A) and HSP60 (B). Loading order, left to right: 1, BAJV104; 2, XPMPDM5; 3, VE1003; 4, VE3303; 5,
BACR104; 6, BAJT104; 7, PARAMA13; L(A), Hyperladder I (Bioline, UK); L(B), Hyperladder V (Bioline, UK).
doi:10.1371/journal.pntd.0001707.g003
Table 3. Oligonucleotide primers employed in this study.
Method Oligunicleotide Secuence Reference
RAPD A1 59-TCACGATGCA Carrasco 1996
RAPD A2 59-GAAACGGGTG Carrasco 1996
RAPD L4 59-GTGGATGCGA Carrasco 1996
RAPD L5 59-AAGAGCCCGT Carrasco 1996
PCR-RFLP GPI(f) 59-GGCATGTGAAGCTTTGAGGCCTTTTTCAG Westenberger 2005
PCR-RFLP GPI(r) 59-TGTAAGGGCCCAGTGAGAGCGTTGGTTTGAATAGC Westenberger 2005
PCR-RFLP HSP60(f) 59-GTGGTATGGGTGACATGTAC Westenberger 2005
PCR-RFLP HSP60(r) 59-CGAGCAGCAGAGCGAAACAT Westenberger 2005
doi:10.1371/journal.pntd.0001707.t003
T. cruzi Genotypes in Venezuela
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Table 4. Reference strains used in this study.
T. cruzi I WA250 cl 10b
T. cruzi II Esmeraldo cl3
T. cruzi III M6241 cl6
T. cruzi IV CanIII cl1
T. cruzi V Sc43 cl1;92.80 cl2
T. cruzi VI CL Brener
doi:10.1371/journal.pntd.0001707.t004
Figure 4. Distribution of Trypanosoma cruzi Discrete Typing Units (DTUs) in Venezuela. The three maps display samples collected from
humans (top left), vectors (top right), and mammal reservoirs (bottom left). Pie chart area is proportional to sampling size. Pie segment colour
represents DTU identity. Inset on each map shows the capital (Caracas) and surrounding states in greater detail.
doi:10.1371/journal.pntd.0001707.g004
Table 5. Summary list of Trypanosoma cruzi genotypes by
host in Venezuela.
Host TcI TcIII TcIV Total
Human 75 0 20 95
Mammals 102 13 0 115
Bugs 555 9 4 568
Total 732 22 24 778
doi:10.1371/journal.pntd.0001707.t005
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identify whether it shares the same risk factors for epizootic
transmission as TcI (e.g. [15,31])
T. cruzi is an extremely successful parasite. Evidence to support
this assertion lies in its continental distribution and the sheer variety
of reservoir hosts it naturally infects. TcI in Venezuela is perhaps
typical of this success, with nine different species infected, including
highly atypical hosts like the collared peccary (Dicotyles tajacu), and
white tailed deer (Odocoileus virginianus). The epidemiological
importance of atypical infections is debatable, either in terms of
maintaining wild parasite transmission, or in representing a risk to
human populations. Of critical relevance to human transmission in
Venezuela are ecotopes dominated by palms (e.g. Attalea sp.), R
prolixus vectors, and Didelphis marsupialis reservoir hosts. As ever, we
isolated the great majority of wild TcI from D. marsupialis, well
known as the primary host of this genotype [4] and for its tendency
to aggregate around human communities [32]. Wild R. prolixus
readily invades houses [24], establishing domestic colonies and
propagating disease among rural communities. Risk factors for
transmission are well established [31], and control strategies can be
designed to maximise successful interruption of transmission.
TcIII, by comparison with TcI, is a less promiscuous DTU. In
common with other studies through South America [22,33], we
isolated this genotype almost exclusively from D. novemcinctus and
its associated triatomine vector P. geniculatus. In non-human cases,
we isolated TcIII with similar global frequency to TcIV (Table 1
and 5). By comparison, no TcIII infection was observed in man,
while TcIV was common. Nonetheless, we did find a TcIII
infected P. geniculatus as a primary domestic disease vector at a peri-
urban focus and it seems remarkable no TcIII was isolated from
man. Similarly, TcIII is largely absent from humans throughout
the rest South America, with only one confirmed report [34].
Together, these data suggest that the restricted host range of TcIII
may be related to more than just transmission ecology. Detailed
genetic, biochemical and biological characterisation of experi-
mental in vitro and in vivo infections could shed light on more
fundamental constraints on TcIII infectivity.
TcI transmission across Latin America is widespread [13,35].
Several vector - reservoir host – ecological niche cliques are
relevant in terms of human disease. Transmission around Caracas
is an important example of the emerging importance of peri-urban
transmission in the impoverished districts of several Latin
American cities [17]. In Caracas rodents (Rattus rattus) are the
primary synantropic host and P. geniculatus the vector (Table 1).
Similarly, TcI transmission is maintained by murid rodents
(although via Triatoma species vectors), in hyper-endemic arid
sub-Andean valleys that impinge on the city of Cochabamba [36].
Peri-urban transmission in Arequipa, Peru, accounts for high
levels of seropositivity even among children [37]. In this case,
however, relevant reservoir host and vectors are less well
characterised. Nonetheless, in Venezuela and elsewhere, control
of disease transmission in an urban environment represents a very
different challenge to that at rural foci. National authorities could
benefit from the sharing of experience in relation to peri-urban
Chagas disease control.
The great majority of human isolates from Caracas charac-
terised in this manuscript originate from several oral Chagas
disease outbreaks in the city. The largest oral outbreak so far
recorded in the city occurred at a school in 2007 [21,38]. It is
thought that over 1000 were exposed, mostly children, among
whom 103 developed infection and one died. Classic epidemio-
logical approaches indentified a contaminated batch of Guava
juice as the likely source, and three isolates typed from patients
and nearby triatomines were TcI. Data presented here do not
include the genotypes of isolates from the 2007 outbreak.
Nevertheless, we have included isolates obtained from P. geniculatus
and R. rattus from the site where the Guava juice was prepared,
which were also TcI. In addition, we did include data from two
further outbreaks, and all human genotypes also correspond to
TcI. The existence of these strains, and accompanying non-human
isolates from the same sites, opens the door to high resolution
molecular epidemiological work to pinpoint the actual source of
these oral cases. Rigorous molecular epidemiological studies can
complement and enhance control recommendations for oral
disease outbreaks, which are currently limited to food hygiene
measures [38], to help prevent future outbreaks and perhaps shed
light on the elevated case mortality rates associated [1].
Several anecdotal reports exist to suggest that human Chagas
disease mega-syndromes are more common in the Southern Cone
region of Latin America [12,13]. This aspect of differential disease
presentation between northern and southern South America is
often circumstantially attributed to the presence of TcII, TcV and
TcVI in the south [13]. Consistent with several current and
historical studies, however, we observed severe cardiac forms of
disease in Venezuela among TcI cases (Nessi et al., manuscript in
preparation). To date, however, we have not detected digestive
forms of the disease. Using high resolution microsatellite markers,
we recently demonstrated a substantial reduction in genetic
diversity among 15 TcI isolates from humans in Venezuela, by
comparison to their silvatic (wild) counterparts [19]. Our analysis
indicated that most human infections originate from the same
genetically depauperate clade, while incursion of strains from the
local silvatic environment was a far rarer event. The remaining 60
human TcI isolates that are uncharacterised by high resolution
markers not only offer considerable scope to test the robustness of
the TcI human clade, but, in conjunction with clinical history,
may also allow us to test the strength of association between TcI
sub-DTU level diversity and disease presentation. Importantly, we
can confirm that a number of human TcIV cases in this study were
symptomatic (Nessi et al., manuscript in preparation) and this
DTU can be considered an epidemiologically important secondary
agent of Chagas disease. High resolution analyses of TcIV isolates
from human cases promise to reveal whether these isolates also
represent a genetically restricted clade.
Chagas disease is potentially re-emergent in Venezuela [39].
The data presented in this manuscript are especially important to
understanding the eco-epidemiology of infection locally as well as
in the context on renewed efforts to interrupt transmission in rural
and urban settings. Vitally, they also lay the groundwork for
future, hypothesis driven research aimed at discovering the
epidemiological/biological relevance of genetic diversity within
the T. cruzi DTUs. For example, it is now technically possible to
identify the sources of emergent peri-urban and oral transmission.
Also, in conjunction with detailed longitudinal clinical data it may
be possible to investigate the impact parasite genetic diversity has
on the outcome of human disease.
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